NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Genre Technical Report ✖Remove constraint Genre: Technical Report Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later Publication Year 2021 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2021">2021</span>

621. Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Author(s):
Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
Subject(s):
Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States

623. Observational real-world evidence update: prophylaxis of hereditary angioedema with Takhzyro and C1 inhibitors : effectiveness and value

Author(s):
Bloudek, Lisa, author
Jaksa, Ashley, author
McKenna, Avery, author
Carlson, Josh, author
Chen, Yilin, author
Patrick, Amanda, author
Campbell, Jon D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 24, 2021
Subject(s):
Angioedemas, Hereditary -- prevention & control
Complement C1 Inhibitor Protein
United States

628. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

Author(s):
Wasfy, Jason H., author
Walton, Surrey M., author
Beinfeld, Molly, author
Nhan, Emily, author
Sarker, Jyotirmoy, author
Whittington, Melanie D., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 16, 2021
Subject(s):
Cardiac Myosins -- antagonists & inhibitors
Cardiomyopathy, Hypertrophic -- drug therapy
United States

629. Tezepelumab for severe asthma: final report

Author(s):
Rind, David M., author
McQueen, Brett, author
Herron-Smith, Serina, author
Herce-Hagiwara, Belén, author
Gutierrez, Éric, author
Fluetsch, Noemi, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 16, 2021
Subject(s):
Antibodies, Monoclonal, Humanized
Asthma -- drug therapy
United States

630. Aducanumab for Alzheimer’s disease: effectiveness and value

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States